New Zealand markets open in 3 hours 33 minutes

Novartis AG (NVS)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
79.69-0.58 (-0.72%)
As of 12:27PM EST. Market open.
Currency in USD

Valuation measures

Market cap (intra-day) 5178.70B
Enterprise value 3204.86B
Trailing P/E 18.64
Forward P/E 112.18
PEG ratio (5-yr expected) 12.14
Price/sales (ttm)3.49
Price/book (mrq)3.18
Enterprise value/revenue 33.91
Enterprise value/EBITDA 710.92

Trading information

Stock price history

Beta (5Y monthly) 0.53
52-week change 3-11.52%
S&P500 52-week change 327.11%
52-week high 398.52
52-week low 379.35
50-day moving average 382.75
200-day moving average 387.63

Share statistics

Avg vol (3-month) 32.14M
Avg vol (10-day) 31.97M
Shares outstanding 52.24B
Implied shares outstanding 6N/A
Float 82.15B
% held by insiders 10.01%
% held by institutions 19.98%
Shares short (14 Nov 2021) 46.15M
Short ratio (14 Nov 2021) 42.65
Short % of float (14 Nov 2021) 4N/A
Short % of shares outstanding (14 Nov 2021) 40.28%
Shares short (prior month 14 Oct 2021) 45.48M

Dividends & splits

Forward annual dividend rate 43.2
Forward annual dividend yield 43.96%
Trailing annual dividend rate 33.40
Trailing annual dividend yield 34.24%
5-year average dividend yield 43.45
Payout ratio 473.88%
Dividend date 314 Mar 2021
Ex-dividend date 403 Mar 2021
Last split factor 21116:1000
Last split date 308 Apr 2019

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Sep 2021


Profit margin 18.72%
Operating margin (ttm)28.34%

Management effectiveness

Return on assets (ttm)7.40%
Return on equity (ttm)17.60%

Income statement

Revenue (ttm)52.39B
Revenue per share (ttm)23.30
Quarterly revenue growth (yoy)6.60%
Gross profit (ttm)35.5B
Net income avi to common (ttm)9.81B
Diluted EPS (ttm)4.33
Quarterly earnings growth (yoy)42.50%

Balance sheet

Total cash (mrq)8.11B
Total cash per share (mrq)3.62
Total debt (mrq)34.33B
Total debt/equity (mrq)60.29
Current ratio (mrq)0.88
Book value per share (mrq)25.38

Cash flow statement

Operating cash flow (ttm)15.19B
Levered free cash flow (ttm)11.92B